ArticleAmerican journal of respiratory and critical care medicine2023
Abstract readLetter
In one paragraph
Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop report.American journal of respiratory cell and molecular biology · 2026Article
- Standardized pipeline for establishing, expanding, and differentiating airway and alveolar organoids from human BAL fluid.American journal of physiology. Lung cellular and molecular physiology · 2026Article
- Genetic and chemical correction of cystic fibrosis reduces airway susceptibility to SARS-CoV-2.American journal of physiology. Lung cellular and molecular physiology · 2026Article
- Standardized pipeline for establishing, expanding, and differentiating airway and alveolar organoids from human BAL fluid.bioRxiv : the preprint server for biology · 2025Article
- Airway Epithelium Derived from Induced Pluripotent Stem Cells to Model Asthma Susceptibility Loci.American journal of respiratory and critical care medicine · 2025Article
- Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine.International journal of molecular sciences · 2025Review
- An in vitro model of the epithelial airway reveals a key function for EHF in lung homeostasis and disease.Disease models & mechanisms · 2025Article
- From Epithelium to Therapy: Transitional Cells in Lung Fibrosis.American journal of respiratory cell and molecular biology · 2025Review
- Do pulmonary ionocytes absorb chloride or secrete chloride?American journal of physiology. Cell physiology · 2025Review
- Recent Advancements in the Generation and Application of Therapeutic Cell Populations for Lung Epithelial Repair.Journal of tissue engineering and regenerative medicine · 2025Review
- The next frontier in lung development and regeneration research: harnessing iPSC models to illuminate notch signaling pathways.Frontiers in cell and developmental biology · 2025Review
- Building a human lung from pluripotent stem cells to model respiratory viral infections.Respiratory research · 2024Review
- Human Airway and Alveolar Organoids from BAL Fluid.American journal of respiratory and critical care medicine · 2024Article
- In vitro platform to model the function of ionocytes in the human airway epithelium.Respiratory research · 2024Article
- Functional Consequences of CFTR Interactions in Cystic Fibrosis.International journal of molecular sciences · 2024Review
- Macrophages and stem/progenitor cells interplay in adipose tissue and skeletal muscle: a review.Stem cell investigation · 2023Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Ruobing WangDivision of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts.ORCID 0000-0003-0277-8329
Chantelle Simone-RoachDivision of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts.
Jonathan Lindstrom-VautrinCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, Massachusetts.
Feiya WangCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, Massachusetts.
Stuart RollinsDivision of Pulmonary Medicine, Boston Children's Hospital, Boston, Massachusetts.
Pushpinder Singh BawaCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, Massachusetts.
Junjie LuCystic Fibrosis Foundation Therapeutics Laboratories, Lexington, Massachusetts.
Yang TangDepartment of Medicine, Harvard Medical School, Boston, Massachusetts.
Mary Lou BeermannCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, Massachusetts.
Thorsten SchlaegerDepartment of Medicine, Harvard Medical School, Boston, Massachusetts.
John MahoneyCystic Fibrosis Foundation Therapeutics Laboratories, Lexington, Massachusetts.
Steven M RoweDepartment of Medicine and the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0001-9045-0133
Finn J HawkinsCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, Massachusetts.
Darrell N KottonCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, Massachusetts.ORCID 0000-0002-9604-8476
Funding
UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI David M. Bedwell · 2007 to 2026
$23.0MDerivation of Transplantable Lung Epithelial Progenitors from iPS CellsR01HL095993 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton · 2009 to 2026
$7.5MA National iPS Cell Network with Deep Phenotyping for Translational ResearchU01TR001810 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GILAD, YOAV, KOTTON, DARRELL N. · 2016 to 2020
$4.4MNATIONAL BIOREPOSITORY OF LUNG DISEASE-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELLS:THE PURPOSE OF THIS RESOURCE IS TO BUILD AND SUPPORT A CRITICAL75N92020C00005 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI N/A, N/A · 2021 to 2024
$2.6MiPSC-Derived Airway Basal Cells to Model Human Airway Development and DiseaseR01HL139799 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAWKINS, FINN · 2018 to 2022
$2.1MUsing Induced Pluripotent Stem Cells to Characterize Cystic FibrosisK08HL155892 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI WANG, RUOBING · 2021 to 2025
$840kNCATS NIH HHS U01 TR001810NHLBI NIH HHS 75N92020C00005NHLBI NIH HHS K08 HL155892NHLBI NIH HHS K08HL155892 (Wang)NHLBI NIH HHS R01 HL095993NHLBI NIH HHS R01 HL139799NHLBI NIH HHS R01HL139799-01A1NIDDK NIH HHS P30 DK072482
Abstract
PubMed holds no abstract for this paper.
Indexed as
Cystic FibrosisInduced Pluripotent Stem CellsCell DifferentiationCell LineCells, CulturedCystic Fibrosis Transmembrane Conductance RegulatorHumansCystic Fibrosis Transmembrane Conductance Regulator
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.